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Abstract 
Pancreatic p-cell-type-specific transcription of the insulin gene is controlled by c&acting sequence lements lying within its enhancer egion. An 
essential element required for expression is the insulin control element (ICE). The activity of this element is regulated by both positive- and 
negative-acting transcription factors. In this study, we have identified the nucleotide sequences within the ICE that are required for repression in 
noninsulin producing cells. Our results indicate that the cis-acting sequences involved in negative control are distinct from those required in activating 
expression in B cells. 
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1. Introduction 
The formation of differentiated pancreatic islet cell 
types during development involves the determination of 
the specific a, 6, and PP islet cell lineages from multipo- 
tential progenitor a-like cells [I]. The specific mecha- 
nisms that regulate cell lineage determination are poorly 
understood. However, studies in cell culture and trans- 
genie mice have demonstrated that transcription of the 
major differentiated products of 01 cells, the hormones 
glucagon (01) and insulin @I), are controlled through the 
interaction of regulatory proteins (trans-acting factors) 
with specific DNA sequences (c&elements) found within 
the 5’-flanking region of each gene [2-61. Restricted ex- 
pression of the insulin gene appears to be regulated by 
both positive- and negative-acting transcription factors 
[71. 
Transcription of the insulin gene is unique to /? cells 
as a result of the interaction of cellular factors with the 
insulin enhancer, which lies between nucleotides -340 
and -91 relative to the transcription start site [7]. Insulin 
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gene enhancer-directed expression is mediated by multi- 
ple c&elements [8-lo]. The most important element reg- 
ulating cell type specific transcription from this region 
appears to be the insulin control element (ICE; 5’- 
GCCATCTGC-3’) [9-l 11, which is conserved within the 
transcription unit of all characterized mammalian insu- 
lin genes at 100 + 14 bp upstream from the transcription 
initiation site [12]. This element alone is capable of di- 
recting /?-cell-specific expression [11,13,14]. These obser- 
vations indicate that the ICE serves a central and general 
role in regulating B-cell-specific expression of the insulin 
gene. 
Regulation of ICE-mediated activity is imparted by 
positive- and negative-acting transcriptional regulators 
[l 11. The truns-acting activator of ICE expression is a 
member of the basic helix-loop-helix family (B-HLH) of 
transcriptional regulators [15-l 71. Analysis of the activi- 
ties of individual point mutations throughout the ICE 
region have shown that the CA and TG bases pairs, 
which defines the binding site for B-HLH proteins (-100 
GCMTCTGCT -91), are crucial for activator function 
[18]. In this study, we have analyzed the DNA sequences 
required for negative regulation by the ICE. Individual 
point mutations within the ICE were constructed and 
their effects on repressor activity analyzed in noninsulin 
producing cells. We found that the base pair at -97 was 
necessary for repressor activity, while mutations at -96, 
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-93 and -91 had little or no effect on activity. Since the 
-93 bp mutation prevents stimulation by the ICE 
B-HLH activator yet has not effect on the repressor 
present in noninsulin producing cells, these studies indi- 
cate that the repressor of ICE-mediated expression is not 
a member of the B-HLH family of transcription factors. 
2. Materials and methods 
2. I. Tissue culture 
HeLa and baby hamster kidney (BHK) cells were grown in mono- 
layer in Dulbeeco’s modified Eagle medium containing 10% (voYvol) 
fetal bovine serum and 50 ,ug each of streptomycin and penicillin per 
ml. HeLa spinner culture cells were grown in Dulbecco modified spin- 
ner medium supplemented with 2.5% (vohvol) fetal bovine serum, 2.5% 
(voUvo1) calf serum, 1 mM L-glutamine, and 1 mM nonessential mino 
acids. 
2.2. DNA constructs 
The mutant -100 expression plasmids were constructed using the 
Amersham oligonucleotide-directed mutagenesis ystem (version 2). 
Single base pair mutations were incorporated into the -100 to -91 bp 
region of the rat insulin II gene at -97 (A to C), -96 (T to G), -93 (G 
to T) and -91 (T to G) in the chloramphenicol acetyltransferase (CAT) 
reporter plasmid -100 CAT [ll]. The luciferase reporter expression 
plasmids were made by subcloning the HindIIYBgfII insulin gene frag- 
ment obtained from the mutant and wild-type -100 and -90 CAT 
plasmids into a Firefly luciferase reporter plasmid, pSVOARPL2L [19]. 
The -97 base pair mutant used in the in vitro transcription studies was 
constructed from a rat insulin II gene expression vector containing 
wild-type sequences from - 100 to + 187 [l 11. The nucleotide sequences 
of all plasmid constructs were confirmed by DNA sequencing analysis. 
Plasmids were prepared by banding twice to equilibrium in cesium 
chloride gradients. 
2.3. DNA transfection and in vivo transcription assays 
Approximately 18 h prior to transfection, 5 x 10’ cells HeLa cells or 
2 x IO* cells BHK cells were plated onto 100 mm’ plates. The DNA 
constructs were introduced as a calcium phosphate coprecipitates made 
up of IO pg of total DNA per plate containing 8 pg of an insulin- 
luciferase reporter plasmid (or carrier pUCl9 DNA) and 2 fig of a 
recovery marker for transfection efficiency, RSV CAT [20], as described 
previously [I I]. At 4 h after addition of the calcium phosphate-DNA 
precipitate, the BHK cells were exposed to 20% glycerol for 2 min. Cells 
were harvested 40 to 48 h after transfection. Cell extracts were prepared 
as described by De Wet et al. [21]. Luciferase and CAT enzymatic 
assays were performed as described previously [21,22]. Each experiment 
was repeated several times with at least two different plasmid prepara- 
tions. 
2.4. In vitro transcription assays 
The cell-free transcription reactions were conducted with HeLa nu- 
clear extracts prepared from HeLa spinner cultures using the procedure 
described by Shapiro et al. [23]. Each reaction contained 8 mM HEPES 
(pH 7.9) 8% v/v glycerol, 7 mM MgCl,, 2.5,ug template DNA, 1 mg/ml 
bovine serum albumin, 75 mM KCI, 80 PM EDTA, 80 PM EGTA, 
80 PM dithiothreitol, 500 PM each of ATP, UTP, GTP and CTP in a 
final assay volume of 25 ~1. Approximately 100 pg of HeLa extract 
protein was preincubated with template DNA for 10 min at 25°C 
followed by the addition of ribonucleotides and the incubation was 
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Fig. I. Expression from ICE mutant constructs. (a) ICE-LUC chimeric gene constructs are shown schematically. The names of the plasmids are listed 
and site of mutation (MT) within the ICE shown. The ICE-LUC chimeric genes were cotransfected into (b) HeLa and (c) BHK cells with an internal 
reporter plasmid, RSV CAT. Normalized luciferase values are presented relative to -9OWT LUC expression as the mean of several independent 
exeriments f standard deviation. The number in parenthesis indicates the number of times each transfection was independently performed. The 
normalized -9OWT LUC luminescence signal was 64,641 and 13,486 in arbitrary light units in HeLa and BHK cells, respectively. The luciferase 
measurements were made with a Analytical Luminescence Laboratory luminometer (Monolight 2010). Standard deviations for the samples are 
indicated by horizontal lines in the histograms. 
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Fig. 2. Analyses of transcripts ynthesized in vitro from the -lOOWT, -97MT and -90WT plasmids. (a) Schematic representation of the -100 and 
-90 wild-type and -97 mutant constructs. (b) Transcription reactions were conducted as described in section 2 using HeLa nuclear extracts. The 
insulin specific primer extension product is labeled. The -1OOWT (lanes 1,2), -97MT (lanes 3,4) and -90WT (lanes 5,6) templates were assayed in 
duplicate. A representative autoradiogram of the resulting analyses is shown. 
continued at 30°C for 1 h. RNA was extracted with phenol/chloroform 
and analyzed by the primer extension methodology [I I]. Insulin-specific 
transcription was analyzed with a primer complementary to bases +33 
to +66 of the noncoding strand of the rat insulin II gene [l 11. The primer 
extension products were visualized by autoradiography. 
3. Results and discussion 
3.1. IdentiJication of the -97 base pair as being required 
for repressor function in vivo 
The ICE alone can direct /?-cell-type-specific expres- 
sion when linked to either the insulin promoter or a 
heterologous minimal promoter [l 1,13,14]. The absence 
of ICE-mediated activity in noninsulin producing cells 
was in part a result of trans-negative regulation [l 11. To 
identify the base pairs within the ICE that are important 
in repressor function, individual transversion mutations 
were made at base pairs -97, -96, -93 and -91 in the 
ICE/insulin promoter expression plasmid, - 1OOWT (Fig. 
1). The effect of these mutations on ICE-directed repres- 
sion were compared to the activity of the insulin pro- 
moter expression plasmid, -9OWT, in two noninsulin 
producing cell lines, BHK and HeLa. We reasoned that 
a mutation at a base pair crucial for repressor interaction 
would result in an increase in activity from -lOOWT 
levels to the level found for the ICE-less promoter ex- 
pression plasmid. 
The results obtained with the insulin/LUG gene ex- 
pression plasmids described in Fig. 1 were normalized to 
expression from a cotransfected Rous sarcoma virus en- 
hancer-driven CAT expression plasmid, RSV CAT. The 
activity of - 1OOWT was approximately tenfold less than 
-90WT. Mutations within the ICE at base pairs -96, 
-93 and -91 did not have any effect on ICE-mediated 
repression, as expression from these constructs was sim- 
ilar to that obtained for -lOOWT. In contrast, the plas- 
mid with a mutation at base pair -97 was much more 
active than -lOOWT. The activity of this mutant was 
comparable to that obtained for -90WT. The same ex- 
pression pattern was found with insulin/CAT constructs 
(data not shown). 
3.2. The ICE mutation at -97 base pair relieves 
ICE-mediated repression in a HeL.a-soluble 
transcription system 
ICE-mediated repression has also been observed in in 
vitro transcription assays [111. To determine whether the 
point mutation at -97 also relieved ICE-mediated re- 
pression in this system, we assayed the relative template 
activity of the -lOOWT, -97MT and -9OWT in a HeLa- 
soluble in vitro transcription extract. Specific in vitro 
transcription products were measured by primer exten- 
sion analyses. The -lOOWT construct was transcribed 
less efficiently than either the insulin promoter, -9OWT, 
or the ICE mutant -97 expression plasmids (Fig. 2b). 
Expression from the -97MT plasmid was similar to 
-9OwT. The pattern of activity from these plasmids is 
identical to that observed in vivo (Fig. 1). 
Together with the in vivo transfection studies, these 
results suggest hat the -97 mutation relieves ICE-medi- 
ated repression in noninsulin producing cells. We believe 
that this mutation decreases the interaction of a negative- 
acting DNA-binding protein with the ICE; however, we 
have not been able to detect any specific repressor-like 
190 R Stein et al. IFEBS Letters 338 (1994) 187-190 
complexes in gel mobility shift assays conducted with 
wild-type and base pair -97 ICE probes (data not 
shown). These results also indicate that the repressor is 
in a functionally distinct class of transcriptional regula- 
tors from the ICE activator since the mutation at -93, 
which disrupts the B-HLH binding site and activation by 
the ICE [ 181, has no effect on repression. 
4. Conclusions 
The mechanisms that control pancreatic /?-cell-specific 
transcription of the insulin gene are not fully understood 
but appear to involve both positive- and negative-acting 
regulatory factors. Previous work has demonstrated that 
selective xpression of the insulin gene is conferred, to a 
large extent, by a single c&acting element found within 
its enhancer, which we have termed the ICE. The nucle- 
otide sequences necessary for activation are those re- 
quired for binding of its B-HLH positive regulator (-98 
MNNTG -93; the nucleotides underlined are essential 
for activation [IS]). In this investigation, we conducted 
a point mutagenesis tudy to identify nucleotides within 
the ICE which are responsible for transcriptional repres- 
sion. Wild-type and mutants in the ICE at base pairs 
-97, -96, -93 and -91 were constructed and their activ- 
ity analyzed in noninsulin producing cells. The mutant 
at base pair -97 was the only one found by both in vivo 
and in vitro functional tests to be crucial for repressor 
action. In contrast, mutations at either -97 and -93 
eliminated ICE-mediated activation [ 181. These results 
clearly indicate that the nucleotide sequences required 
for activation are distinct from those necessary for re- 
pression. 
The ICE activator appears to be induced during islet 
development prior to insulin gene transcription [24]. In- 
terestingly, MyoD, a key B-HLH transcriptional regula- 
tor important in muscle determination is also induced 
prior to differentiation [25]. The absence of transcription 
of B-HLH protein activated muscle target genes appears 
to be a result of the activity of negative-acting regulators 
[2628]. By analogy, these results indicate that repression 
mechanisms function to regulate ICE-mediated tran- 
scription. To address this question, we are working to- 
wards isolating the factor(s) involved in negative control 
of ICE-mediated expression. 
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